Provided by Tiger Fintech (Singapore) Pte. Ltd.

GeneDx Holdings

66.85
-50.1200-42.85%
Post-market: 67.400.5500+0.82%16:08 EDT
Volume:7.60M
Turnover:536.36M
Market Cap:1.91B
PE:-34.38
High:83.41
Open:81.97
Low:63.71
Close:116.97
Loading ...

Stock Track | GeneDx Holdings Plunges 23.06% Pre-market Despite Strong Q1 Revenue, Investors Concerned About Profitability

Stock Track
·
Yesterday

Why GeneDx Holdings Stock Is Plunging Today

Motley Fool
·
3 hours ago

BUZZ-GeneDx set for worst day on record despite Q1 results beat

Reuters
·
3 hours ago

GeneDx Holdings Down Nearly 39%, On Pace For Record Percent Decrease -- Data Talk

Dow Jones
·
Yesterday

S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results

Benzinga
·
Yesterday

Stock Track | GeneDx Holdings Plummets 33.68% Pre-Market Despite Q1 Revenue Beat as Profitability Concerns Loom

Stock Track
·
Yesterday

GeneDx Holdings Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Yesterday

GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates

Zacks
·
Yesterday

GeneDx Q1 Loss Narrows, Revenue Rises; 2025 Revenue Outlook Raised

MT Newswires Live
·
Yesterday

3 Stocks Estimated To Be Trading Below Their Intrinsic Value In April 2025

Simply Wall St.
·
Yesterday

Stock Track | GeneDx Holdings Plunges 23% Pre-market Despite Q1 Revenue Beat, Investors Focus on Profitability Concerns

Stock Track
·
Yesterday

Earnings Flash (WGS) GeneDx Holdings Posts Q1 Loss of $0.23 per Share, vs. FactSet Est of $0.27 Loss per Share

MT Newswires Live
·
Yesterday

GeneDx Hldgs Q1 Adj. EPS $0.27 Beats $0.16 Estimate, Sales $87.11M Beat $85.13M Estimate

Benzinga
·
Yesterday

BRIEF-GeneDx Q1 Revenue USD 87.1 Million Vs. IBES Estimate USD 79.5 Million

Reuters
·
Yesterday

GeneDx Holdings Corp Outlook Full Year Revenues Between $360 to $375 Mln

THOMSON REUTERS
·
Yesterday

Press Release: GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

Dow Jones
·
Yesterday

GeneDx Shares Rise 3.9% Premarket Ahead of Q1 Results

THOMSON REUTERS
·
Yesterday

GENEDX HOLDINGS (WGS) Upgraded to Buy: Here's Why

Zacks
·
Yesterday

Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting

GlobeNewswire
·
26 Apr

GeneDx Holdings Corp. (WGS): Among the Best Multibagger Stocks to Buy According to Billionaires

Insider Monkey
·
24 Apr